Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD.
Zhou XD, Li YT, Kim SU, Yip TC, Petta S, Nakajima A, Tsochatzis E, Shi J, Chan WK, Boursier J, Bugianesi E, Yilmaz Y, Hagström H, Romero-Gomez M, Alswat K, Calleja JL, Takahashi H, de Lédinghen V, Shalimar, Castéra L, Sanyal AJ, Goh GB, Newsome PN, Fan JG, Lai M, Aggarwal S, Kechagias S, Hiasa Y, Zhang Z, George J, El-Kassas M, Chen J, You H, Abu Dayyeh BK, Sheng H, Adams LA, Wang J, He F, Liang H, Yang YF, Chi X, Zhong B, Bi Y, Mi Y, Zhu Y, Bai R, Zhang J, Wang B, Song J, Deng H, Xie Q, Bai L, Xin Y, Xie W, Li J, Fournier-Poizat C, Wu C, Lee HW, Lai-Hung Wong G, Armandi A, Shang Y, Pennisi G, Llop E, Yoneda M, de Saint-Loup M, Lara-Romero C, Gallego-Durán R, Asgharpour A, Kim-Jun Teh K, Sau-Wai Chan M, Lin H, Liu WY, Song SJ, Al-Hamoudi WK, Isoda H, Miyake T, Satapathy SK, Li M, Sharma K, Emadeldeen M, Zhou L, Tong X, Bazerbachi F, Fan X, Xiao H, Ye J, Xu L, Wang X, Wei YX, Zoncape M, Li W, Wong VW, Zheng MH; VCTE-Prognosis Study Group; Paired Liver Biopsy Group.
Zhou XD, et al. Among authors: fan x.
Clin Gastroenterol Hepatol. 2025 Jul 24:S1542-3565(25)00622-6. doi: 10.1016/j.cgh.2025.07.011. Online ahead of print.
Clin Gastroenterol Hepatol. 2025.
PMID: 40714381